Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
出版年份 2019 全文链接
标题
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
作者
关键词
-
出版物
RHEUMATOLOGY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-10-15
DOI
10.1093/rheumatology/kez525
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib – A report of two cases
- (2019) Sarah Wendel et al. JOURNAL OF AUTOIMMUNITY
- Successful Treatment for Refractory Interstitial Lung Disease and Pneumomediastinum With Multidisciplinary Therapy Including Tofacitinib in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis
- (2019) Manami Kato et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
- (2019) Charalampia Papadopoulou et al. BRAIN
- JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
- (2018) Leandro Ladislau et al. BRAIN
- Aberrant activation of type I interferon system may contribute to the pathogenesis of anti-MDA5 dermatomyositis
- (2018) S.H. Zhang et al. BRITISH JOURNAL OF DERMATOLOGY
- Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis
- (2018) Jessie Aouizerate et al. RHEUMATOLOGY
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- OUP accepted manuscript
- (2018) BRAIN
- OUP accepted manuscript
- (2018) BRAIN
- New insights in myositis-specific autoantibodies
- (2018) Anna Ghirardello et al. CURRENT OPINION IN RHEUMATOLOGY
- Detection in whole blood of autoantibodies for the diagnosis of connective tissue diseases in near patient testing condition
- (2018) Makoto Miyara et al. PLoS One
- Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies
- (2018) Kubéraka Mariampillai et al. JAMA Neurology
- Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features
- (2018) Shireena A. Yasin et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib
- (2018) Siamak Moghadam-Kia et al. RHEUMATOLOGY
- Anti-MDA5 Antibody Spectrum in Western World
- (2018) Siamak Moghadam-Kia et al. Current Rheumatology Reports
- Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histological Features
- (2018) Gian Marco Moneta et al. Arthritis & Rheumatology
- Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
- (2017) Isabelle Melki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Detection of interferon alpha protein reveals differential levels and cellular sources in disease
- (2017) Mathieu P. Rodero et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Photonic ring resonance is a versatile platform for performing multiplex immunoassays in real time
- (2017) Sasi Mudumba et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A case of refractory dermatomyositis responsive to tofacitinib
- (2017) Julie J. Paik et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells
- (2017) Marie-Louise Frémond et al. Arthritis & Rheumatology
- Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies
- (2016) Yves Allenbach et al. AMERICAN JOURNAL OF PATHOLOGY
- AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
- (2016) Steffen Meyer et al. CELL
- Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)
- (2016) Cécile Picard et al. CHEST
- Recent advances in dermatomyositis-specific autoantibodies
- (2016) Manabu Fujimoto et al. CURRENT OPINION IN RHEUMATOLOGY
- Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
- (2016) Marie-Louise Frémond et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
- (2016) Gillian I. Rice et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes
- (2016) L. G. Rider et al. JOURNAL OF INTERNAL MEDICINE
- Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
- (2016) Nicolino Ruperto et al. LANCET
- Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease
- (2016) Hironao Hozumi et al. RESPIRATORY MEDICINE
- Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies
- (2016) L. Ekholm et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis
- (2016) Claire T. Deakin et al. Arthritis & Rheumatology
- Inflammatory Muscle Diseases
- (2015) Marinos C. Dalakas NEW ENGLAND JOURNAL OF MEDICINE
- Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations
- (2014) Nadia Jeremiah et al. JOURNAL OF CLINICAL INVESTIGATION
- Redefining Dermatomyositis
- (2014) Yves Troyanov et al. MEDICINE
- Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis
- (2014) Yoshiro Horai et al. Modern Rheumatology
- Remission of Recalcitrant Dermatomyositis Treated with Ruxolitinib
- (2014) Thorsten Hornung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study
- (2014) Sarah L Tansley et al. ARTHRITIS RESEARCH & THERAPY
- Brief Report: Interferon-α Induction and Detection of Anti-Ro, Anti-La, Anti-Sm, and Anti-RNP Autoantibodies by Autoantigen Microarray Analysis in Juvenile Dermatomyositis
- (2013) Imelda Balboni et al. ARTHRITIS AND RHEUMATISM
- Requirement of Inducible Nitric Oxide Synthase for Skeletal Muscle Regeneration after Acute Damage
- (2013) E. Rigamonti et al. JOURNAL OF IMMUNOLOGY
- The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
- (2012) Dragana Lazarevic et al. ANNALS OF THE RHEUMATIC DISEASES
- Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis
- (2011) S A Greenberg et al. GENES AND IMMUNITY
- Serum levels of interferon do not correlate with disease activity in patients with dermatomyositis/polymyositis
- (2010) P. Krol et al. ANNALS OF THE RHEUMATIC DISEASES
- Interferon is associated with type 1 interferon-inducible gene expression in dermatomyositis
- (2010) A. P. Liao et al. ANNALS OF THE RHEUMATIC DISEASES
- Elevated serum interferon-α activity in juvenile dermatomyositis: Associations with disease activity at diagnosis and after thirty-six months of therapy
- (2009) Timothy B. Niewold et al. ARTHRITIS AND RHEUMATISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started